Vitamin D in Clinical Medicine. Группа авторов

ultra-performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 2008;391:1917–1930.

65Kissmeyer AM, Sonne K: Sensitive analysis of 1alpha,25-dihydroxyvitamin D3 in biological fluids by liquid chromatography-tandem mass spectrometry. J Chromatogr A 2001;935:93–103.

66Casetta B, Jans I, Billen J, Vanderschueren D, Bouillon R: Development of a method for the quantification of 1alpha,25(OH)2-vitamin D3 in serum by liquid chromatography tandem mass spectrometry without derivatization. Eur J Mass Spectrom (Chichester) 2010;16:81–89.

67Singh RJ, Taylor RL, Reddy GS, Grebe SK: C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab 2006;91:3055–3061.

68Wang Z, Senn T, Kalhorn T, Zheng XE, Zheng S, Davis CL, et al: Simultaneous measurement of plasma vitamin D(3) metabolites, including 4beta,25-dihydroxyvitamin D(3), using liquid chromatography-tandem mass spectrometry. Anal Biochem 2011;418:126–133.

69Cashman KD, Hayes A, Galvin K, Merkel J, Jones G, Kaufmann M, et al: Significance of serum 24,25-dihydroxyvitamin D in the assessment of vitamin D status: a double-edged sword? Clin Chem 2015;61:636–645.

70Duan X, Weinstock-Guttman B, Wang H, Bang E, Li J, Ramanathan M, et al: Ultrasensitive quantification of serum vitamin D metabolites using selective solid-phase extraction coupled to microflow liquid chromatography and isotope-dilution mass spectrometry. Anal Chem 2010;82:2488–2497.

71Higashi T, Sakajiri K, Shimada K: Analysis of C-3 epimerization in (24R)-24,25-dihydroxyvitamin D3 catalyzed by hydroxysteroid dehydrogenase. J Pharm Biomed Anal 2004;36:429–436.

72Tanaka Y, Frank H, DeLuca HF, Koizumi N, Ikekawa N: Importance of the stereochemical position of the 24-hydroxyl to biological activity of 24-hydroxyvitamin D3. Biochemistry 1975;14:3293–3296.

73Burild A, Frandsen HL, Jakobsen J: Simultaneous quantification of vitamin D(3), 25-hydroxyvitamin D(3) and 24,25-dihydroxyvitamin D(3) in human serum by LC-MS/MS. Scand J Clin Lab Invest 2014;74:418–423.

74Ogawa S, Ooki S, Shinoda K, Higashi T: Analysis of urinary vitamin D(3) metabolites by liquid chromatography/tandem mass spectrometry with ESI-enhancing and stable isotope-coded derivatization. Anal Bioanal Chem 2014;406:6647–6654.

75Shah I, Petroczi A, Naughton DP: Method for simultaneous analysis of eight analogues of vitamin D using liquid chromatography tandem mass spectrometry. Chem Cent J 2012;6:112.

76Bikle DD, Halloran BP, Gee E, Ryzen E, Haddad JG: Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels. J Clin Invest 1986;78:748–752.

77Bikle DD, Gee E, Halloran B, Haddad JG: Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest 1984;74:1966–1971.

78Lai JC, Bikle DD, Lizaola B, Hayssen H, Terrault NA, Schwartz JB: Total 25(OH) vitamin D, free 25(OH) vitamin D and markers of bone turnover in cirrhotics with and without synthetic dysfunction. Liver Int 2015;35:2294–2300.

79Bikle DD, Siiteri PK, Ryzen E, Haddad JG: Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J Clin Endocrinol Metab 1985;61:969–975.

      80Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG: Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab 1986;63:954–959.

81Boutin B, Galbraith RM, Arnaud P: Comparative affinity of the major genetic variants of human group-specific component (vitamin D-binding protein) for 25-(OH) vitamin D. J Steroid Biochem 1989;32:59–63.

82Nielson CM, Jones KS, Chun RF, Jacobs JM, Wang Y, Hewison M, et al: Free 25-hydroxyvitamin D: impact of vitamin D binding protein assays on racialgenotypic associations. J Clin Endocrinol Metab 2016;101:2226–2234.

83Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, et al: Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 2013;369:1991–2000.

84Denburg MR, Hoofnagle AN, Sayed S, Gupta J, de Boer IH, Appel LJ, et al: Comparison of two ELISA methods and mass spectrometry for measurement of vitamin D-binding protein: implications for the assessment of bioavailable vitamin D concentrations across genotypes. J Bone Min Res 2016;31:1128–1136.

85Schwartz JB, Lai J, Lizaola B, Kane L, Markova S, Weyland P, et al: A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations. J Clin Endocrinol Metab 2014;99:1631–1637.

      Daniel D. Bikle, MD, PhD

      VA Medical Center and University of California San Francisco

      1700 Owens St., Rm 373

      San Francisco, CA 94158 (USA)

      E-Mail [email protected]

      Giustina A, Bilezikian JP (eds): Vitamin D in Clinical Medicine.

      Front Horm Res. Basel, Karger, 2018, vol 50, pp 31–41 (DOI: 10.1159/000486063)

      ______________________

Vitamin D-Binding Protein

Tatiane Vilaça^a · Marise Lazaretti-Castro^b

^aAcademic Unit of Bone Metabolism, University of Sheffield, Sheffield, UK; ^bDivision of Endocrinology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil

      ______________________

      Abstract

      Vitamin D-binding protein (DBP) is the main transporter of vitamin D metabolites, initially described as a “group-specific